Reported Q: Q1 2025 Rev YoY: -13.0% EPS YoY: -61.5% Move: 0.00%
Precision Optics
PEYE
$1.950 0.00%
Exchange OTC Sector Healthcare Industry Medical Instruments Supplies
Q1 2025
Published: Nov 14, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for PEYE

Reported

Report Date

Nov 14, 2024

Quarter Q1 2025

Revenue

4.20M

YoY: -13.0%

EPS

-0.21

YoY: -61.5%

Market Move

0.00%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $4.20M down 13% year-over-year
  • EPS of $-0.21 decreased by 61.5% from previous year
  • Gross margin of 26.6%
  • Net income of -1.31M
  • "N/A" - N/A
PEYE
Company PEYE

Executive Summary

Precision Optics reported QQ1 2025 revenue of $4.197 million, down 13.0% year-over-year and 11.0% quarter-over-quarter. Gross profit was $1.118 million with a gross margin of 26.6%, yet the company posted an operating loss of $1.247 million and a net loss of $1.311 million, translating to an EPS of −$0.21. The quarter marks continued profitability challenges amid a modest improvement in some cost lines but persistent top-line and operating-leverage headwinds. The cash flow profile remains negative from operations, with FCF at −$0.343 million and a cumulative cash balance of $0.636 million, underscoring liquidity and funding needs as the business navigates a low-growth environment in the niche medical imaging space. On the balance sheet, total assets stand at $17.24 million with goodwill of $9.11 million and total liabilities of $7.10 million; stockholders’ equity sits at $10.14 million. The company carries total debt of $2.74 million and net debt of $2.10 million, with current liquidity metrics showing a current ratio of 1.41 and a quick ratio of 0.76, signaling moderate near-term liquidity but modest cushion to weather further downside. Management commentary is not embedded in the provided data; as a result, the forward-looking view relies on the quantitative signal set and industry context. Investors should monitor operating leverage progress, potential improvements in working capital efficiency, and any strategic actions that could unlock value given the sizable goodwill balance.

Key Performance Indicators

Revenue
Decreasing
4.20M
QoQ: -11.01% | YoY: -13.00%
Gross Profit
Decreasing
1.12M
26.62% margin
QoQ: 9.07% | YoY: -22.99%
Operating Income
Decreasing
-1.25M
QoQ: 8.07% | YoY: -77.08%
Net Income
Decreasing
-1.31M
QoQ: 7.08% | YoY: -72.80%
EPS
Decreasing
-0.21
QoQ: 8.70% | YoY: -61.54%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 4.19 -0.30 -20.2% View
Q2 2025 4.53 -0.15 -9.9% View
Q1 2025 4.20 -0.21 -13.0% View
Q4 2024 4.72 -0.23 +9.1% View
Q3 2024 5.24 -0.05 +3.9% View